Schlesinger et al., 1949 - Google Patents
Liver damage in gastro-enteritisSchlesinger et al., 1949
View PDF- Document ID
- 7057115415343412294
- Author
- Schlesinger B
- Payne W
- Burnard E
- Publication year
- Publication venue
- Archives of Disease in Childhood
External Links
Snippet
(From the Hospital for Sick Children, Great Ormond Street, London) Jaundice in gastro- enteritis is described as a rare terminal event (Sakula, 1943) and has been com-monly regarded as a manifestation of septicaemia, as for instance in Buhl's disease (Capon, 1934) …
- 208000005577 Gastroenteritis 0 title abstract description 20
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER, CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using micro-organisms or enzymes
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Govan Jr et al. | The use of potassium chloride in the treatment of the dehydration of diarrhea in infants | |
West et al. | The effect of cholestyramine on intestinal absorption. | |
Michaelsson | Zinc therapy in acrodermatitis enteropathica | |
Copeland et al. | Nutritional aspects of cancer | |
Hyman et al. | Parenteral and oral alimentation in the treatment of the nonspecific protracted diarrheal syndrome of infancy | |
Oates | Infant-feeding practices | |
Kenya et al. | Cereal based oral rehydration solutions. | |
Anderson et al. | Use of parenteral nutrition in treatment of advanced regional enteritis | |
Elkington | Lactulose. | |
May et al. | Notes concerning the cause and treatment ofceliac disease | |
Schlesinger et al. | Liver damage in gastro-enteritis | |
AINGER et al. | Familial athyreotic cretinism: report of 3 cases | |
Keating et al. | Amino acid-hypertonic glucose treatment for intractable diarrhea in infants | |
Giordano et al. | Effects of catabolic stress in acute and chronic renal failure | |
Doxiadis | Idiopathic renal acidosis in infancy | |
Corner | Hypertrophic pyloric stenosis in infancy treated with methyl scopolamine nitrate | |
Graham et al. | Lactose-free, medium-chain triglyceride formulas in severe malnutrition | |
Mann et al. | A deficiency state arising in infants on synthetic foods | |
OKUDA et al. | The thyroid and absorption of vitamin B12 in rats | |
US3256150A (en) | Method for treating malabsorption syndrome | |
Litchfield et al. | Effect of yeast extract (Vitamin B complex) on growth and development of premature infants | |
Chan | Dietary management of renal failure in infants and children: principles of nutritional therapy and some representative diets | |
Banister et al. | Intravenous feeding of young infants with persistent diarrhoea | |
Partington et al. | The prophylactic use of folic acid in neonatal hypertyrosinemia | |
Williams et al. | Hydrolysed casein for parenteral administration to infants |